These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 23774198)

  • 1. Quantitative and qualitative spectral domain optical coherence tomography analysis of subretinal deposits in patients with acute central serous retinopathy.
    Landa G; Barnett JA; Garcia PM; Tai KW; Rosen RB
    Ophthalmologica; 2013; 230(2):62-8. PubMed ID: 23774198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time-periodic characteristics in the morphology of idiopathic central serous chorioretinopathy evaluated by volume scan using spectral-domain optical coherence tomography.
    Song IS; Shin YU; Lee BR
    Am J Ophthalmol; 2012 Aug; 154(2):366-375.e4. PubMed ID: 22633348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of subretinal exudation and consequent changes in acute central serous chorioretinopathy by optical coherence tomography.
    Yu J; Jiang C; Xu G
    Am J Ophthalmol; 2014 Oct; 158(4):752-756.e2. PubMed ID: 24973608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Morphologic changes in acute central serous chorioretinopathy evaluated by spectral domain optical coherence tomography].
    Yu H; Xia GY; Gao MH; Yu J; Zhang YY
    Zhonghua Yan Ke Za Zhi; 2011 Jun; 47(6):508-15. PubMed ID: 21914265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of features on SD-OCT between acute central serous chorioretinopathy and exudative age-related macular degeneration.
    Ahn SJ; Kim TW; Huh JW; Yu HG; Chung H
    Ophthalmic Surg Lasers Imaging; 2012; 43(5):374-82. PubMed ID: 22767337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BASELINE SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHIC HYPERREFLECTIVE FOCI AS A PREDICTOR OF VISUAL OUTCOME AND RECURRENCE FOR CENTRAL SEROUS CHORIORETINOPATHY.
    Lee H; Lee J; Chung H; Kim HC
    Retina; 2016 Jul; 36(7):1372-80. PubMed ID: 26702841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinal and choroidal changes with severe hypertension and their association with visual outcome.
    Ahn SJ; Woo SJ; Park KH
    Invest Ophthalmol Vis Sci; 2014 Nov; 55(12):7775-85. PubMed ID: 25395485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does microperimetry have a prognostic value in central serous chorioretinopathy?
    Roisman L; Ribeiro JC; Fechine FV; Lavinsky D; Moraes N; Campos M; Farah ME
    Retina; 2014 Apr; 34(4):713-8. PubMed ID: 23975001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical factors related to visual outcome in central serous chorioretinopathy.
    Aggio FB; Roisman L; Melo GB; Lavinsky D; Cardillo JA; Farah ME
    Retina; 2010; 30(7):1128-34. PubMed ID: 20616688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between spectral-domain optical coherence tomography findings and visual outcome after primary rhegmatogenous retinal detachment repair.
    Gharbiya M; Grandinetti F; Scavella V; Cecere M; Esposito M; Segnalini A; Gabrieli CB
    Retina; 2012 Jan; 32(1):43-53. PubMed ID: 21778929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mineralocorticoid receptor antagonism in the treatment of chronic central serous chorioretinopathy: a pilot study.
    Bousquet E; Beydoun T; Zhao M; Hassan L; Offret O; Behar-Cohen F
    Retina; 2013; 33(10):2096-102. PubMed ID: 23719402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Segregation of ophthalmoscopic characteristics according to choroidal thickness in patients with early age-related macular degeneration.
    Switzer DW; Mendonça LS; Saito M; Zweifel SA; Spaide RF
    Retina; 2012 Jul; 32(7):1265-71. PubMed ID: 22222760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphologic changes in acute central serous chorioretinopathy evaluated by fourier-domain optical coherence tomography.
    Fujimoto H; Gomi F; Wakabayashi T; Sawa M; Tsujikawa M; Tano Y
    Ophthalmology; 2008 Sep; 115(9):1494-500, 1500.e1-2. PubMed ID: 18394706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subfoveal choroidal thickness in fellow eyes of patients with central serous chorioretinopathy.
    Maruko I; Iida T; Sugano Y; Ojima A; Sekiryu T
    Retina; 2011 Sep; 31(8):1603-8. PubMed ID: 21487334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between retinal and choroidal thickness and visual acuity in highly myopic eyes.
    Flores-Moreno I; Ruiz-Medrano J; Duker JS; Ruiz-Moreno JM
    Br J Ophthalmol; 2013 Aug; 97(8):1010-3. PubMed ID: 23766433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of Heidelberg retinal tomography and spectral domain optical coherence tomography examinations for detection of glaucoma].
    Piasecka K; Bednarski M; Nawrocka Z; Nawrocki J; Michalewska Z
    Klin Oczna; 2013; 115(2):125-9. PubMed ID: 24059028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between morphological characteristics in spectral-domain-optical coherence tomography, different functional tests and a patient's subjective handicap in acute central serous chorioretinopathy.
    Gerendas BS; Kroisamer JS; Buehl W; Rezar-Dreindl SM; Eibenberger KM; Pablik E; Schmidt-Erfurth U; Sacu S
    Acta Ophthalmol; 2018 Nov; 96(7):e776-e782. PubMed ID: 29338130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy.
    Imamura Y; Fujiwara T; Margolis R; Spaide RF
    Retina; 2009; 29(10):1469-73. PubMed ID: 19898183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-resolution imaging of resolved central serous chorioretinopathy using adaptive optics scanning laser ophthalmoscopy.
    Ooto S; Hangai M; Sakamoto A; Tsujikawa A; Yamashiro K; Ojima Y; Yamada Y; Mukai H; Oshima S; Inoue T; Yoshimura N
    Ophthalmology; 2010 Sep; 117(9):1800-9, 1809.e1-2. PubMed ID: 20673590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optical coherence tomography-assisted enhanced depth imaging of central serous chorioretinopathy.
    Yang L; Jonas JB; Wei W
    Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4659-65. PubMed ID: 23737472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.